Position in ICLR
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$3,995
+$2,668 QoQ
Shares Held
23
+91.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#380
of 422 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ICLR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Fortitude Family Office, LLC holds $543,961 across 28 Diagnostics & Research names. ICLR ranks #17 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IQV |
Iqvia Holdings Inc.
|
378 | $73,037 | |
| 2 | DHR |
Danaher Corp /De/
|
373 | $71,049 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
128 | $64,174 | |
| 4 | ILMN |
Illumina, Inc.
|
321 | $56,441 | |
| 5 | NTRA |
Natera, Inc.
|
183 | $49,675 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
80 | $42,115 | |
| 7 | MEDP |
Medpace Holdings, Inc.
|
63 | $33,364 | |
| 8 | WAT |
Waters Corp /De/
|
84 | $31,503 |
All Filings in ICLR
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,995 | 23 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,327 | 12 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $911 | 5 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $1,050 | 6 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $872 | 6 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $8,749 | 50 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $10,485 | 50 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $14,365 | 50 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $15,673 | 50 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $16,797 | 50 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $14,153 | 50 | Shares | Sole | 2024-01-12 | |
| No filing history on record for this holder in this stock. | ||||||